Abstract Details
|
Kate Daniello, MD, FÂ鶹´«Ã½Ó³»
(University of Massachusetts)
PRESENTER |
Dr. Daniello has nothing to disclose. |
| Melissa L. Rayhill, MD, FÂ鶹´«Ã½Ó³» (UBMD Neurology/University At Buffalo SUNY) | Dr. Rayhill has received personal compensation in the range of $500-$4,999 for serving as a Presenter with Headache Cooperative of New England. Dr. Rayhill has received personal compensation in the range of $500-$4,999 for serving as a Presenter with Clusterbusters. Dr. Rayhill has received personal compensation in the range of $500-$4,999 for serving as a Presenter with Â鶹´«Ã½Ó³». |
| Ania Busza, MD, PhD (University of Rochester) | Dr. Busza has received research support from NIH/NINDS. Dr. Busza has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH. |
| Judith A. Clark | No disclosure on file |
| James Otis, MD, FÂ鶹´«Ã½Ó³» | Dr. Otis has nothing to disclose. |
| Massimo Filippi, MD, FÂ鶹´«Ã½Ó³» (Ospedale San Raffaele, Neuroimaging Research Unit) | Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla. |